Adam Havey, EVP, Biodefense Divison at Emergent BioSolutions Inc. (EBS), bought 98 shares at $27.08 ($3K) on 2015-06-01, disclosed to the SEC on 2015-06-02.
Open-market purchase of $3k EBS by EVP, Biodefense Divison. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |